Morfina 2% Braun (Morphine Hydrochloride Trihydrate)

Morphine Hydrochloride Trihydrate, the active ingredient in Morfina 2% Braun, is an opioid analgesic presented as a 2% w/v solution for epidural, intramuscular and intrathecal use. It treats severe acute pain, postoperative pain, cancer pain, labor analgesia and chronic pain requiring opioid therapy.

GNH USA supplies Morfina 2% Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and clinics worldwide.

Morphine, an opioid analgesic, is used for pain management across several clinical settings.

- Severe acute pain: provides rapid relief of intense pain episodes. - Post‑operative pain: reduces pain following surgical procedures. - Cancer pain: controls persistent malignant pain. - Labor analgesia: offers effective analgesia during childbirth. - Chronic pain requiring opioid therapy: maintains baseline pain control in selected patients.

Morphine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: feeling of queasiness often occurring shortly after administration. - Vomiting: forceful expulsion of stomach contents. - Constipation: reduced bowel motility leading to hard stools. - Drowsiness: increased sleepiness or reduced alertness. - Pruritus: itching, especially around the face and neck. - Sweating: excessive perspiration unrelated to temperature.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - Severe hypotension: marked drop in blood pressure causing dizziness or fainting. - Addiction or dependence: development of physical or psychological reliance on the drug.

When using morphine, clinicians should observe several safety measures.

- Assess pain level before initiating therapy: determine baseline severity and goals. - Monitor respiratory function regularly: watch for reduced rate or depth of breathing. - Adjust dose in renal or hepatic impairment: reduce dosage or increase interval as needed. - Avoid use with other central nervous system depressants: limit concurrent benzodiazepines or barbiturates. - Use caution in elderly or debilitated patients: start with lower doses and titrate slowly. - Store at controlled room temperature: keep in original container, protect from light and moisture.

Morphine interacts with several drug classes that can modify its safety or efficacy.

Major Interactions (Avoid): - Other opioids: additive respiratory depression and sedation. - Central nervous system depressants (e.g., benzodiazepines, alcohol): heightened risk of profound sedation. - Monoamine oxidase inhibitors (MAOIs): can precipitate severe hypertension or serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin, ketoconazole): may increase morphine plasma levels. - CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce analgesic effect. - Drugs that prolong QT interval: monitor cardiac rhythm for arrhythmias.